SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(((8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl-16,16,17-d3)oxy)tetrahydro-2H-pyran-2-carboxylic acid
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: C[C@@]12[C@](CC([2H])([2H])[C@]2([2H])O)([H])[C@@](CCC3=C4)([H])[C@@](CC1)([H])C3=CC=C4O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]([C@H]5O)C(O)=O
17β-Estradiol-3-β-D-Glucuronide-D3 is chemically (2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-(((8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl-16,16,17-d3)oxy)tetrahydro-2H-pyran-2-carboxylic acid. 17β-Estradiol-3-β-D-Glucuronide-D3 is supplied with detailed characterization data compliant with regulatory guideline. 17β-Estradiol-3-β-D-Glucuronide-D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Estradiol Valerate.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Validated RP-HPLC method for the determination of estradiol valerate in bulk and pharmaceutical formulations
M. Madhu1 *, Satyadev T. N. V. S. S.1 , G. Hephzibah1 and T. V. Reddy
Der Pharmacia Lettre, 2016, 8 (4):50-61
Determination of estradiol and its degradation products by liquid chromatography
Lucie Havlíková, Lucie Nováková, Ludmila Matysová, Jan Sícha
Journal of Chromatography A 1119(1-2):216-23
Determination of Related Substances in Estradiol Valerate Tablet by Use of HPLC Method
Du, Biying
Current Pharmaceutical Analysis, Volume 14, Number 5, 2018, pp. 513-518(6)